Peptide Characterization and Functional Stability of a Partially Hydrolyzed Whey-Based Formula over Time

Human clinical trials have shown that a specific partially hydrolyzed 100% whey-based infant formula (pHF-W) reduces AD risk in the first yeast of life. Meta-analyses with a specific pHF-W (pHF-W1) confirm a protective effect while other meta-analyses pooling different pHF-W show conflicting results...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourdeau, Tristan, Affolter, Michael, Dupuis, Lénaïck, Panchaud, Alexandre, Lahrichi, Sabine, Merminod, Loraine, Martin-Paschoud, Christine, Adams, Rachel, Nutten, Sophie, Blanchard, Carine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465316/
https://www.ncbi.nlm.nih.gov/pubmed/34578889
http://dx.doi.org/10.3390/nu13093011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465316/
https://www.ncbi.nlm.nih.gov/pubmed/34578889
http://dx.doi.org/10.3390/nu13093011

Ejemplares similares